Editorial board member John Wilding discusses the lessons for healthcare professionals from the SGLT2 inhibitor cardiovascular outcome trials about the benefits and drawbacks of the medication class (14:07).
08-09-2017 | SGLT2 inhibitors | Video
08-09-2017 | SGLT2 inhibitors | Video
Editorial board member John Wilding discusses the lessons for healthcare professionals from the SGLT2 inhibitor cardiovascular outcome trials about the benefits and drawbacks of the medication class (14:07).